BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27372228)

  • 1. [Standard of care of carcinomas on cancer of unknown primary site in 2016].
    Benderra MA; Ilié M; Hofman P; Massard C
    Bull Cancer; 2016; 103(7-8):697-705. PubMed ID: 27372228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cancer of unknown primary site origin--advances in diagnosis and therapy].
    Plot L; Dovrish Z; Hadari R; Weisenberg N; Zehavi T; Nisenbaum B; Amital H
    Harefuah; 2008 Apr; 147(4):294-8, 376, 375. PubMed ID: 18686808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid biopsy: a new diagnostic, predictive and prognostic window in cancers of unknown primary.
    El Rassy E; Khaled H; Pavlidis N
    Eur J Cancer; 2018 Dec; 105():28-32. PubMed ID: 30388661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carcinoma unknown primary-clinical practice].
    Onozawa Y
    Gan To Kagaku Ryoho; 2014 Jul; 41(7):799-803. PubMed ID: 25131862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoma of unknown primary (CUP).
    Pavlidis N; Fizazi K
    Crit Rev Oncol Hematol; 2009 Mar; 69(3):271-8. PubMed ID: 18977667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Liver metastases with unknown primary site].
    Drug VL; Popa I; Cijevschi C; Miron L; Mitrică D; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(2):298-305. PubMed ID: 14755931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer from an unknown primary site.
    Dowell JE
    Am J Med Sci; 2003 Jul; 326(1):35-46. PubMed ID: 12861124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of measuring circulating tumor cell counts to assess the efficacy of treatment for carcinomas of unknown primary origin.
    Komine K; Inoue M; Otsuka K; Fukuda K; Nanjo H; Shibata H
    Anticancer Res; 2014 Jun; 34(6):3165-8. PubMed ID: 24922689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Biology to Diagnosis and Treatment: The Ariadne's Thread in Cancer of Unknown Primary.
    Mathew BG; Aliyuda F; Taiwo D; Adekeye K; Agada G; Sanchez E; Ghose A; Rassy E; Boussios S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to Diagnose and Treat a Cancer of Unknown Primary Site.
    Tomuleasa C; Zaharie F; Muresan MS; Pop L; Fekete Z; Dima D; Frinc I; Trifa A; Berce C; Jurj A; Berindan-Neagoe I; Zdrenghea M
    J Gastrointestin Liver Dis; 2017 Mar; 26(1):69-79. PubMed ID: 28338116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical recommendations for diagnosis, treatment and monitoring of patients with cancer of unknown primary site].
    Bišof V; Juretić A; Trivanović D; Dintinjana RD; Sarçević B; Jakić-Razumović J; Ban M; Bošković L; Mise B-; Bura M; Stančić-Rokotov D
    Lijec Vjesn; 2015; 137(3-4):65-9. PubMed ID: 26065281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Standards, Options and Recommendations for the management of patient with carcinoma of unknown primary site].
    Bugat R; Bataillard A; Lesimple T; Voigt JJ; Culine S; Lortholary A; Merrouche Y; Ganem G; Kaminsky MC; Negrier S; Perol M; Laforêt C; Bedossa P; Bertrand G; Coindre JM; Fizazi K;
    Bull Cancer; 2002 Oct; 89(10):869-75. PubMed ID: 12441278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of patients with cancer of unknown primary site.
    Hainsworth JD; Greco FA
    Oncology (Williston Park); 2000 Apr; 14(4):563-74; discussion 574-6, 578-9. PubMed ID: 10826316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and therapy of tumors from an unknown primary site].
    Novik AV; Moiseenko VM
    Vopr Onkol; 2004; 50(3):271-8. PubMed ID: 15318700
    [No Abstract]   [Full Text] [Related]  

  • 15. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP).
    Briasoulis E; Tolis C; Bergh J; Pavlidis N;
    Ann Oncol; 2005; 16 Suppl 1():i75-6. PubMed ID: 15888766
    [No Abstract]   [Full Text] [Related]  

  • 16. The diagnostic challenges of patients with carcinoma of unknown primary.
    Rassy E; Pavlidis N
    Expert Rev Anticancer Ther; 2020 Sep; 20(9):775-783. PubMed ID: 32779501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SEOM clinical guideline on unknown primary cancer (2017).
    Losa F; Soler G; Casado A; Estival A; Fernández I; Giménez S; Longo F; Pazo-Cid R; Salgado J; Seguí MÁ
    Clin Transl Oncol; 2018 Jan; 20(1):89-96. PubMed ID: 29230692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer of unknown primary site.
    Pavlidis N; Pentheroudakis G
    Lancet; 2012 Apr; 379(9824):1428-35. PubMed ID: 22414598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Space-occupying lesions in the liver: incidence of adenocarcinoma metastases of unknown primary site].
    Eickhoff A; Spiethoff A; Hartmann D; Jakobs R; Weickert U; Schilling D; Eickhoff JC; Bohrer MH; Riemann JF
    Dtsch Med Wochenschr; 2007 Feb; 132(8):369-74. PubMed ID: 17299675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of unknown primary tumors].
    Dodion P; De Valeriola D
    Bull Cancer; 1989; 76(9):939-46. PubMed ID: 2695183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.